Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munir Alam

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|April 6, 2012
Immune-correlates analysis of an HIV-1 vaccine efficacy trialBarton F Haynes, Peter B Gilbert, M Juliana McElrath, et al.
Nature|April 5, 2013
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virusHua-Xin Liao, Rebecca Lynch, Tongqing Zhou, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeysKevin O Saunders, Esther Lee, Robert Parks, et al.
Nature Communications|November 25, 2017
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizationsWilton B Williams, Jinsong Zhang, Chuancang Jiang, et al.
Mbio|January 11, 2023
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing AntibodiesFrederic Bibollet-Ruche, Ronnie M Russell, Wenge Ding, et al.
Plos Pathogens|August 4, 2015
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesSampa Santra, Georgia D Tomaras, Ranjit Warrier, et al.
Science Translational Medicine|March 17, 2017
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodiesMattia Bonsignori, Edward F Kreider, Daniela Fera, et al.
Cell|May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Science (New York, N.Y.)|August 1, 2015
HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodiesWilton B Williams, Hua-Xin Liao, M Anthony Moody, et al.
JCI Insight|December 13, 2016
Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaquesKan Luo, Hua-Xin Liao, Ruijun Zhang, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|April 6, 2012
Immune-correlates analysis of an HIV-1 vaccine efficacy trialBarton F Haynes, Peter B Gilbert, M Juliana McElrath, et al.
Nature|April 5, 2013
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virusHua-Xin Liao, Rebecca Lynch, Tongqing Zhou, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeysKevin O Saunders, Esther Lee, Robert Parks, et al.
Nature Communications|November 25, 2017
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizationsWilton B Williams, Jinsong Zhang, Chuancang Jiang, et al.
Mbio|January 11, 2023
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing AntibodiesFrederic Bibollet-Ruche, Ronnie M Russell, Wenge Ding, et al.
Plos Pathogens|August 4, 2015
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesSampa Santra, Georgia D Tomaras, Ranjit Warrier, et al.
Science Translational Medicine|March 17, 2017
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodiesMattia Bonsignori, Edward F Kreider, Daniela Fera, et al.
Cell|May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Science (New York, N.Y.)|August 1, 2015
HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodiesWilton B Williams, Hua-Xin Liao, M Anthony Moody, et al.
JCI Insight|December 13, 2016
Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaquesKan Luo, Hua-Xin Liao, Ruijun Zhang, et al.
Pageof 21